Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

STC Biologics opens doors to new site
June 2019
SHARING OPTIONS:

NEWTON, Mass.—Construction is complete on STC Biologics’ single-use mammalian GMP manufacturing facility, the company announced recently, and the first MCB and first three GMP drug substance production runs have already been conducted. The Newton, Mass.-based facility features state-of-the-art equipment, including a Finesse controller, a Thermo Scientific HyPerforma 500L Single-Use Bioreactor and GE ÄKTA Ready purification skids.
 
“We selected Newton, Mass. for our manufacturing site because of its proximity to the hub of biotechnology. We have an open-door policy, where clients can drop by to discuss their projects with our scientists and see their data in real time,” said Dr. Magdalena Leszczyniecka, president and CEO of STC Biologics, adding that “The strategic investments and clear expansion path demonstrate our commitment to support clients through all stages of product development.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.